Clinical trial Recruiting at 12 sites Observational Ages 18 and up

Creating a biorepository of biofluids and clinical data for ALS research

Official title: Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At - Home Measures

Run by Target ALS Foundation, Inc. · NCT05137665 · Data updated 2026-11-12

This study is collecting blood, spinal fluid, and urine samples from people with ALS and healthy individuals to help find new ways to understand and treat the disease.

More Amyotrophic Lateral Sclerosis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorTarget ALS Foundation, Inc.
Academic / other
Locations12 sites (Phoenix, Arizona and 11 other locations)
StatusRecruiting
StartedJune 1, 2021
Main results expectedDecember 31, 2031
Study endsDecember 31, 2031
Registry record updatedNovember 21, 2025
Trial IDNCT05137665 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 or older with a confirmed diagnosis of ALS and the ability to comply with study procedures.

Probably not a fit

Patients with neurological diseases other than ALS or those with known ALS-associated genetic mutations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a biorepository of longitudinal biofluids, including blood, cerebrospinal fluid, and urine, linked to genetic and clinical information from patients with Amyotrophic Lateral Sclerosis (ALS) and healthy controls. Over a five-year period, 800 ALS patients and 200 healthy participants will be enrolled from various global sites. Participants will undergo regular clinical assessments and provide biofluid samples, which will be stored in a de-identified manner for future research. The goal is to facilitate the identification and validation of ALS biomarkers to enhance drug development.

Why it matters

Potential benefit: If successful, this study could significantly advance the understanding and treatment of ALS by providing critical biomarker data for future research.

How similar studies have gone: Previous studies have attempted similar approaches but have been limited in sample size, making this biorepository a potentially novel and valuable resource.

Who can join: the full rules

Show full inclusion / exclusion criteria
ALS Participants:

1. Age 18 or older.
2. A diagnosis of ALS in accordance with Gold Coast criteria.
3. Full Vital Capacity (FVC) of ≥30% or at the discretion of the Principal Investigator for the participant's predicted value for gender, height, and age at the time of screening.
4. Ability to provide informed consent and understand the purpose and risks of the study.
5. Ability to comply with study procedures and assessments, in the opinion of the Principal Investigator.

Healthy Control Participants:

1. Age 18 or older.
2. No history of neurological disease, in the opinion of the Principal Investigator.
3. No known ALS- associated genetic mutations at the time of consent.
4. Ability to provide informed consent and understand the purpose and risks of the study.
5. Ability to comply with study procedures and assessments, in the opinion of the Principal Investigator.

Where it's running

  • Barrow Neurological Institute
    Phoenix, Arizona, United States
    Recruiting
  • University of California San Diego
    San Diego, California, United States
    Recruiting
  • Georgetown University
    Georgetown, District of Columbia, United States
    Recruiting
  • Mayo Clinic
    Jacksonville, Florida, United States
    Recruiting
  • Northwestern University
    Chicago, Illinois, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
Show 6 more locations
  • Washington University
    St Louis, Missouri, United States
    Recruiting
  • Columbia University
    New York, New York, United States
    Recruiting
  • Baylor College of Medicine
    Houston, Texas, United States
    Recruiting
  • University of Washington
    Seattle, Washington, United States
    Recruiting
  • Instituto Roosevelt
    Bogotá, Colombia
    Recruiting
  • CHALS-CCT UPR MScience
    San Juan, Puerto Rico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • How physical functioning relates to quality of life for people with ALS at TidalHealth

    This study will see if physical functioning scores relate to quality of life for adults with ALS who receive care at TidalHealth Peninsula Regional.

    Recruiting TidalHealth · Salisbury, Maryland · NCT07491484

  • Acamprosate for ALS with C9orf72 mutation

    This study tests whether acamprosate can be safely used to see if it helps people with ALS who carry a C9orf72 mutation.

    Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07204977

  • Observational study on amyotrophic lateral sclerosis

    This study is collecting health information from people with ALS, those with related genetic mutations, and healthy volunteers to help improve treatments and understand the disease better.

    Recruiting ALS Therapy Development Institute · Watertown, Massachusetts · NCT06885918

  • Collecting data on neurodegenerative diseases progression markers

    This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.

    Recruiting IRCCS San Raffaele Roma · Cassino, Frosinone · NCT06596746

  • Understanding the variability in ALS through biomarkers

    This study is trying to see how different biological markers can help us understand the varying symptoms of ALS in patients and group them based on their unique characteristics.

    Recruiting at 3 sites Istituto Auxologico Italiano · Milan, MI and 2 other locations · NCT06318598

  • Creating a database to study variations in motor neuron diseases

    This study is trying to learn more about the different types of motor neuron diseases in patients to better understand the condition and improve how we predict its course.

    Recruiting Istituto Auxologico Italiano · Milan, MI · NCT06318585

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.